Neurocrine Biosciences
NBIX
#1351
Rank
HK$104.51 B
Marketcap
HK$1,032
Share price
4.78%
Change (1 day)
9.98%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Net assets

Net assets on the balance sheet as of September 2024 : HK$21.13 Billion

According to Neurocrine Biosciences 's latest financial reports the company has HK$21.13 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Neurocrine Biosciences - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$HK$17.43 B30.64%
2022-12-31$HK$13.34 B24.54%
2021-12-31$HK$10.71 B22.72%
2020-12-31$HK$8.73 B76.01%
2019-12-31$HK$4.96 B31.75%
2018-12-31$HK$3.76 B29.49%
2017-12-31$HK$2.90 B19.08%
2016-12-31$HK$2.44 B-25.78%
2015-12-31$HK$3.28 B103.23%
2014-12-31$HK$1.61 B73.37%
2013-12-31$HK$0.93 B-21.97%
2012-12-31$HK$1.19 B156.42%
2011-12-31$HK$0.46 B209.97%
2010-12-31$HK$0.15 B391.05%
2009-12-31$HK$30.65 M-89.21%
2008-12-31$HK$0.28 B-69.29%
2007-12-31$HK$0.92 B-62.19%
2006-12-31$HK$2.44 B-19.07%
2005-12-31$HK$3.02 B-1.17%
2004-12-31$HK$3.06 B0.95%
2003-12-31$HK$3.03 B73.35%
2002-12-31$HK$1.74 B-27.74%
2001-12-31$HK$2.42 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
HK$15.68 B-25.83%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$79.76 B 277.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
-HK$59.76 Million-100.28%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$111.34 B 426.71%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$47.20 B 123.29%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$719.65 B 3,304.24%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.34 B-84.16%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$0.29 Billion-101.34%๐Ÿ‡บ๐Ÿ‡ธ USA